Referências
Principais artigos
Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association. Circulation. 2015 Oct 13;132(15):1435-86.Texto completo Resumo
Delgado V, Ajmone Marsan N, de Waha S, et al. 2023 ESC guidelines for the management of endocarditis. Eur Heart J. 2023 Oct 14;44(39):3948-4042.Texto completo Resumo
Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint Committee on clinical practice guidelines. Circulation. 2021 Feb 2;143(5):e72-227.Texto completo
Wilson WR, Gewitz M, Lockhart PB, et al. Prevention of viridans group streptococcal infective endocarditis: a scientific statement from the American Heart Association. Circulation. 2021 May 18;143(20):e963-78.Texto completo Resumo
Artigos de referência
1. Mylonakis E, Calderwood SB. Medical progress: infective endocarditis in adults. N Engl J Med. 2001 Nov 1;345(18):1318-30. Resumo
2. Tleyjeh IM, Steckelberg JM. Changing epidemiology of infective endocarditis. Curr Infect Dis Rep. 2006 Jun;8(4):265-70. Resumo
3. Baddour LM, Weimer MB, Wurcel AG, et al. Management of infective endocarditis in people who inject drugs: a scientific statement from the American Heart Association. Circulation. 2022 Oct 4;146(14):e187-201.Texto completo Resumo
4. Tleyjeh IM, Steckelberg JM, Murad HS, et al. Temporal trends in infective endocarditis: a population-based study in Olmsted County, Minnesota. JAMA. 2005 Jun 22;293(24):3022-8.Texto completo Resumo
5. Tornos P, Iung B, Permanyer-Miralda G, et al. Infective endocarditis in Europe: lessons from the Euro heart survey. Heart. 2005 May;91(5):571-5.Texto completo Resumo
6. Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association. Circulation. 2015 Oct 13;132(15):1435-86.Texto completo Resumo
7. Delgado V, Ajmone Marsan N, de Waha S, et al. 2023 ESC guidelines for the management of endocarditis. Eur Heart J. 2023 Oct 14;44(39):3948-4042.Texto completo Resumo
8. Sanghavi R, Ravikumar N, Sarodaya V, et al. Outcomes in cardiac implantable electronic device-related infective endocarditis: a systematic review of current literature. Future Cardiol. 2022 Nov;18(11):891-9.Texto completo Resumo
9. Atar D, Auricchio A, Blomström-Lundqvist C. Cardiac device infection: removing barriers to timely and adequate treatment. Eur Heart J. 2023 Sep 14;44(35):3323-6.Texto completo Resumo
10. Baddour LM, Esquer Garrigos Z, Rizwan Sohail M, et al. Update on cardiovascular implantable electronic device infections and their prevention, diagnosis, and management: a scientific statement from the American Heart Association: endorsed by the International Society for Cardiovascular Infectious Diseases. Circulation. 2024 Jan 9;149(2):e201-16.Texto completo Resumo
11. Blomstrom-Lundqvist C, Ostrowska B. Prevention of cardiac implantable electronic device infections: guidelines and conventional prophylaxis. Europace. 2021 May 25;23(suppl 4):iv11-9.Texto completo Resumo
12. American Heart Association. Bridging gaps in awareness, detection and appropriate treatment of CIED infections. 2022 [internet publication].Texto completo
13. Greenspon AJ, Prutkin JM, Sohail MR, et al. Timing of the most recent device procedure influences the clinical outcome of lead-associated endocarditis results of the MEDIC (Multicenter Electrophysiologic Device Infection Cohort). J Am Coll Cardiol. 2012 Feb 14;59(7):681-7.Texto completo Resumo
14. Carozza A, De Santo LS, Romano G, et al. Infective endocarditis in intravenous drug abusers: patterns of presentation and long-term outcomes of surgical treatment. J Heart Valve Dis. 2006 Jan;15(1):125-31. Resumo
15. Miró JM, del Río A, Mestres CA. Infective endocarditis and cardiac surgery in intravenous drug abusers and HIV-1 infected patients. Cardiol Clin. 2003 May;21(2):167-84. Resumo
16. Frontera JA, Gradon JD. Right-side endocarditis in injection drug users: review of proposed mechanisms of pathogenesis. Clin Infect Dis. 2000 Feb;30(2):374-9.Texto completo Resumo
17. Talha KM, Baddour LM, Thornhill MH, et al. Escalating incidence of infective endocarditis in Europe in the 21st century. Open Heart. 2021 Oct;8(2):e001846.Texto completo Resumo
18. Pant S, Patel NJ, Deshmukh A, et al. Trends in infective endocarditis incidence, microbiology, and valve replacement in the United States from 2000 to 2011. J Am Coll Cardiol. 2015 May 19;65(19):2070-6.Texto completo Resumo
19. Kadri AN, Wilner B, Hernandez AV, et al. Geographic trends, patient characteristics, and outcomes of infective endocarditis associated with drug abuse in the United States from 2002 to 2016. J Am Heart Assoc. 2019 Oct;8(19):e012969.Texto completo Resumo
20. Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint Committee on clinical practice guidelines. Circulation. 2021 Feb 2;143(5):e72-227.Texto completo
21. Rajani R, Klein JL. Infective endocarditis: a contemporary update. Clin Med (Lond). 2020 Jan;20(1):31-5.Texto completo Resumo
22. Noubiap JJ, Nkeck JR, Kwondom BS, et al. Epidemiology of infective endocarditis in Africa: a systematic review and meta-analysis. Lancet Glob Health. 2022 Jan;10(1):e77-86.Texto completo Resumo
23. Hubers SA, DeSimone DC, Gersh BJ, et al. Infective endocarditis: a contemporary eview. Mayo Clin Proc. 2020 May;95(5):982-97.Texto completo Resumo
24. Onofrei VA, Adam CA, Marcu DTM, et al. Infective endocarditis during pregnancy-keep it safe and simple!. Medicina (Kaunas). 2023 May 12;59(5):939.Texto completo Resumo
25. Murdoch DR, Corey GR, Hoen B, et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med. 2009 Mar 9;169(5):463-73.Texto completo Resumo
26. Ioannou P, Kourtidis M, Mytilinis DO, et al. Whipple's disease-associated infective endocarditis: a systematic review. Infect Dis (Lond). 2023 Jul;55(7):447-57. Resumo
27. Ioannou P, Baliou S, Papakitsou I, et al. Infective endocarditis by Actinomyces species: a systematic review. J Chemother. 2023 Apr;35(2):87-94. Resumo
28. Velidakis A, Degaitis F, Tsorbatzoglou G, et al. Infective endocarditis by Nocardia species: a systematic review. J Chemother. 2023 May;35(3):173-80. Resumo
29. Zhang X, Jin F, Ni F, et al. Clinical data analysis of 86 patients with invasive infections caused by Malassezia furfur from a tertiary medical center and 37 studies. Front Cell Infect Microbiol. 2023 Jun 29:13:1079535.Texto completo Resumo
30. Ioannou P, Alexakis K, Spentzouri D, et al. Infective endocarditis by Serratia species: a systematic review. J Chemother. 2022 Oct;34(6):347-59. Resumo
31. Ioannou P, Vamvoukaki R, Kofteridis DP. Infective endocarditis by Enterobacter cloacae: a systematic review and meta-analysis. J Chemother. 2022 Feb;34(1):1-8. Resumo
32. Sanchez-Nadales A, Diaz-Sierra A, Mocadie M, et al. Advanced cardiovascular imaging for the diagnosis of Mycobacterium chimaera prosthetic valve infective endocarditis after open-heart surgery: a contemporary systematic review. Curr Probl Cardiol. 2022 Dec;47(12):101392. Resumo
33. Franconieri F, Join-Lambert O, Creveuil C, et al. Rothia spp. infective endocarditis: a systematic literature review. Infect Dis Now. 2021 May;51(3):228-35.Texto completo Resumo
34. Ioannou P, Miliara E, Baliou S, et al. Infective endocarditis by Klebsiella species: a systematic review. J Chemother. 2021 Oct;33(6):365-74. Resumo
35. Bashore TM, Cabell C, Fowler V Jr. Update on infective endocarditis. Curr Probl Cardiol. 2006 Apr;31(4):274-352. Resumo
36. Saeed K, Bal AM, Gould IM, et al. An update on Staphylococcus aureus infective endocarditis from the International Society of Antimicrobial Chemotherapy (ISAC). Int J Antimicrob Agents. 2019 Jan;53(1):9-15.
37. Ando T, Ashraf S, Villablanca PA, et al. Meta-analysis comparing the incidence of infective endocarditis following transcatheter aortic valve implantation versus surgical aortic valve replacement. Am J Cardiol. 2019 Mar 1;123(5):827-32. Resumo
38. Hassanin A, Afify H, Zook S, et al. Infective endocarditis after transcatheter aortic valve implantation: a systematic review. Cardiol Rev. 2023 Mar-Apr 01;31(2):93-8. Resumo
39. Ullah W, Khan MS, Gowda SN, et al. Prosthetic valve endocarditis in patients undergoing TAVR compared to SAVR: a systematic review and meta-analysis. Cardiovasc Revasc Med. 2020 Dec;21(12):1567-72. Resumo
40. Wilson WR, Gewitz M, Lockhart PB, et al. Prevention of viridans group streptococcal infective endocarditis: a scientific statement from the American Heart Association. Circulation. 2021 May 18;143(20):e963-78.Texto completo Resumo
41. Borghi A, Ciuffreda M, Quattrociocchi M, et al. The grown-up congenital cardiac patient. J Cardiovasc Med (Hagerstown). 2007 Jan;8(1):78-82. Resumo
42. Jordan AM, Tatum R, Ahmad D, et al. Infective endocarditis following heart transplantation: a systematic review. Transplant Rev (Orlando). 2022 Jan;36(1):100672. Resumo
43. Ioannou P, Papakitsou I, Kofteridis DP. Fungal endocarditis in transplant recipients: a systematic review. Mycoses. 2020 Sep;63(9):952-63. Resumo
44. Ioannou P, Alexakis K, Kofteridis DP. Endocarditis in kidney transplant recipients: a systematic review. J Chemother. 2021 Sep;33(5):269-75. Resumo
45. Ann HW, Ahn JY, Jeon YD, et al. Incidence of and risk factors for infectious complications in patients with cardiac device implantation. Int J Infect Dis. 2015 Jul;36:9-14.Texto completo Resumo
46. Pressman GS, Rodriguez-Ziccardi M, Gartman CH, et al. Mitral annular calcification as a possible nidus for endocarditis: a descriptive series with bacteriological differences noted. J Am Soc Echocardiogr. 2017 Jun;30(6):572-8. Resumo
47. Morningstar JE, Nieman A, Wang C, et al. Mitral valve prolapse and its motley crew-syndromic prevalence, pathophysiology, and progression of a common heart condition. J Am Heart Assoc. 2021 Jul 6;10(13):e020919.Texto completo Resumo
48. Zegri-Reiriz I, de Alarcón A, Muñoz P, et al. Infective Endocarditis in Patients With Bicuspid Aortic Valve or Mitral Valve Prolapse. J Am Coll Cardiol. 2018 Jun 19;71(24):2731-40.Texto completo Resumo
49. Sims JR, Anavekar NS, Bhatia S, et al. Clinical, radiographic, and microbiologic features of infective endocarditis in patients with hypertrophic cardiomyopathy. Am J Cardiol. 2018 Feb 15;121(4):480-4. Resumo
50. Jaltotage B, Ali U, Dorai-Raj A, et al. Q fever endocarditis: a review of local and all reported cases in the literature. Heart Lung Circ. 2021 Oct;30(10):1509-15. Resumo
51. Habib G, Iung B. Antibiotics for prevention of endocarditis: time to scale up? not yet!. Heart. 2023 Jan 11;109(3):166-7.
52. Quan TP, Muller-Pebody B, Fawcett N, et al. Investigation of the impact of the NICE guidelines regarding antibiotic prophylaxis during invasive dental procedures on the incidence of infective endocarditis in England: an electronic health records study. BMC Med. 2020 Apr 2;18(1):84.Texto completo Resumo
53. Vähäsarja N, Lund B, Ternhag A, et al. Infective endocarditis among high-risk individuals before and after the cessation of antibiotic prophylaxis in dentistry: a national cohort study. Clin Infect Dis. 2022 Sep 30;75(7):1171-8.Texto completo Resumo
54. Williams ML, Doyle MP, McNamara N, et al. Epidemiology of infective endocarditis before versus after change of international guidelines: a systematic review. Ther Adv Cardiovasc Dis. 2021 Jan-Dec;15:17539447211002687.Texto completo Resumo
55. Cahill TJ, Harrison JL, Jewell P, et al. Antibiotic prophylaxis for infective endocarditis: a systematic review and meta-analysis. Heart. 2017 Jun;103(12):937-44. Resumo
56. Lockhart PB, Brennan MT, Sasser HC, et al. Bacteremia associated with toothbrushing and dental extraction. Circulation. 2008 Jun 17;117(24):3118-25.Texto completo Resumo
57. Thornhill MH, Gibson TB, Yoon F, et al. Antibiotic prophylaxis against infective endocarditis before invasive dental procedures. J Am Coll Cardiol. 2022 Sep 13;80(11):1029-41.Texto completo Resumo
58. Lean SSH, Jou E, Ho JSY, et al. Prophylactic antibiotic use for infective endocarditis: a systematic review and meta-analysis. BMJ Open. 2023 Aug 22;13(8):e077026.Texto completo Resumo
59. Sperotto F, France K, Gobbo M, et al. Antibiotic prophylaxis and infective endocarditis incidence following invasive dental procedures: a systematic review and meta-analysis. JAMA Cardiol. 2024 Jul 1;9(7):599-610. Resumo
60. Rutherford SJ, Glenny AM, Roberts G, et al. Antibiotic prophylaxis for preventing bacterial endocarditis following dental procedures. Cochrane Database Syst Rev. 2022 May 10;5(5):CD003813.Texto completo Resumo
61. National Institute for Health and Care Excellence. Prophylaxis against infective endocarditis: antimicrobial prophylaxis against infective endocarditis in adults and children undergoing interventional procedures. Jul 2016 [internet publication].Texto completo
62. Selton-Suty C, Hoen B, Grentzinger A, et al. Clinical and bacteriological characteristics of infective endocarditis in the elderly. Heart. 1997 Mar;77(3):260-3.Texto completo Resumo
63. Habib G, Badano L, Tribouilloy C, et al. Recommendations for the practice of echocardiography in infective endocarditis. Eur J Echocardiogr. 2010 Mar;11(2):202-19. Resumo
64. Xie P, Zhuang X, Liu M, et al. An appraisal of clinical practice guidelines for the appropriate use of echocardiography for adult infective endocarditis-the timing and mode of assessment (TTE or TEE). BMC Infect Dis. 2021 Jan 21;21(1):92.Texto completo Resumo
65. Evans L, Rhodes A, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Crit Care Med. 2021 Nov 1;49(11):e1063-143.Texto completo
66. Lamy B, Dargère S, Arendrup MC, et al. How to optimize the use of blood cultures for the diagnosis of bloodstream infections? a state-of-the art. Front Microbiol. 2016 May 12:7:697.Texto completo Resumo
67. Habib G, Derumeaux G, Avierinos JF, et al. Value and limitations of the Duke criteria in the diagnosis of infective endocarditis. J Am Coll Cardiol. 1999 Jun;33(7):2023-9.Texto completo Resumo
68. American Society for Microbiology. Five things physicians and patients should question. Choosing Wisely, an initiative of the ABIM Foundation. 2022 [internet publication].Texto completo
69. Hu W, Wang X, Su G. Infective endocarditis complicated by embolic events: pathogenesis and predictors. Clin Cardiol. 2021 Mar;44(3):307-15.Texto completo Resumo
70. American College of Radiology. ACR appropriateness criteria: infective endocarditis. 2020 [internet publication].Texto completo
71. Galzerano D, Kinsara AJ, Di Michele S, et al. Three dimensional transesophageal echocardiography: a missing link in infective endocarditis imaging? Int J Cardiovasc Imaging. 2020 Mar;36(3):403-13. Resumo
72. Sanchez-Nadales A, Cedeño J, Sonnino A, et al. Utility of intracardiac echocardiography for infective endocarditis and cardiovascular device-related endocarditis: a contemporary systematic review. Curr Probl Cardiol. 2023 Sep;48(9):101791. Resumo
73. Porter TR, Airey K, Quader M. Mitral valve endocarditis presenting as complete heart block. Tex Heart Inst J. 2006;33(1):100-1.Texto completo Resumo
74. DiNubile MJ, Calderwood SB, Steinhaus DM, et al. Cardiac conduction abnormalities complicating native valve active infective endocarditis. Am J Cardiol. 1986 Dec 1;58(13):1213-7. Resumo
75. Jain V, Wang TKM, Bansal A, et al. Diagnostic performance of cardiac computed tomography versus transesophageal echocardiography in infective endocarditis: a contemporary comparative meta-analysis. J Cardiovasc Comput Tomogr. 2021 Jul-Aug;15(4):313-21. Resumo
76. Expert Panel on Cardiac Imaging, Malik SB, Hsu JY, et al. ACR appropriateness criteria infective endocarditis. J Am Coll Radiol. 2021 May;18(5s):S52-61.Texto completo Resumo
77. Feuchtner GM, Stolzmann P, Dichtl W, et al. Multislice computed tomography in infective endocarditis: comparison with transesophageal echocardiography and intraoperative findings. J Am Coll Cardiol. 2009 Feb 3;53(5):436-44.Texto completo Resumo
78. Snygg-Martin U, Gustafsson L, Rosengren L, et al. Cerebrovascular complications in patients with left-sided infective endocarditis are common: a prospective study using magnetic resonance imaging and neurochemical brain damage markers. Clin Infect Dis. 2008 Jul 1;47(1):23-30.Texto completo Resumo
79. Ahn Y, Joo L, Suh CH, et al. Impact of brain MRI on the diagnosis of infective endocarditis and treatment decisions: systematic review and meta-analysis. AJR Am J Roentgenol. 2022 Jun;218(6):958-68.Texto completo Resumo
80. Hess A, Klein I, Iung B, et al. Brain MRI findings in neurologically asymptomatic patients with infective endocarditis. AJNR Am J Neuroradiol. 2013 Aug;34(8):1579-84.Texto completo Resumo
81. Saby L, Laas O, Habib G, et al. Positron emission tomography/computed tomography for diagnosis of prosthetic valve endocarditis: increased valvular 18F-fluorodeoxyglucose uptake as a novel major criterion. J Am Coll Cardiol. 2013 Jun 11;61(23):2374-82. Resumo
82. O'Gorman P, Nair L, Kisiel N, et al. Meta-analysis assessing the sensitivity and specificity of (18)F-FDG PET/CT for the diagnosis of prosthetic valve endocarditis (PVE) using individual patient data (IPD). Am Heart J. 2023 Jul;261:21-34. Resumo
83. Mahmood M, Kendi AT, Ajmal S, et al. Meta-analysis of 18F-FDG PET/CT in the diagnosis of infective endocarditis. J Nucl Cardiol. 2019 Jun;26(3):922-35. Resumo
84. Wang TKM, Sánchez-Nadales A, Igbinomwanhia E, et al. Diagnosis of infective endocarditis by subtype using (18)F-fluorodeoxyglucose positron emission tomography/computed tomography: a contemporary meta-analysis. Circ Cardiovasc Imaging. 2020 Jun;13(6):e010600.Texto completo Resumo
85. Bourque JM, Birgersdotter-Green U, Bravo PE, et al. 18F-FDG PET/CT and radiolabeled leukocyte SPECT/CT imaging for the evaluation of cardiovascular infection in the multimodality context: ASNC imaging indications (ASNC I2) Series Expert Consensus recommendations from ASNC, AATS, ACC, AHA, ASE, EANM, HRS, IDSA, SCCT, SNMMI, and STS. Clin Infect Dis. 11 Mar 2024 [Epub ahead of print].Texto completo Resumo
86. Simundic AM, Bölenius K, Cadamuro J, et al. Joint EFLM-COLABIOCLI recommendation for venous blood sampling. Clin Chem Lab Med 2018;56(12):2015-38. Resumo
87. Reynolds HR, Jagen MA, Tunick PA, et al. Sensitivity of transthoracic versus transesophageal echocardiography for the detection of native valve vegetations in the modern era. J Am Soc Echocardiogr. 2003 Jan;16(1):67-70. Resumo
88. Feldmen T. Rheumatic heart disease. Curr Opin Cardiol. 1996 Mar;11(2):126-30. Resumo
89. Lopez JA, Ross RS, Fishbein MC, et al. Nonbacterial thrombotic endocarditis: a review. Am Heart J. 1987 Mar;113(3):773-84. Resumo
90. Malhotra A, Prendergast BD. Evaluating treatment options for patients with infective endocarditis: when is it the right time for surgery? Future Cardiol. 2012 Nov;8(6):847-61. Resumo
91. Chirillo F, Scotton P, Rocco F, et al. Impact of a multidisciplinary management strategy on the outcome of patients with native valve infective endocarditis. Am J Cardiol. 2013 Oct 15;112(8):1171-6. Resumo
92. Botelho-Nevers E, Thuny F, Casalta JP, et al. Dramatic reduction in infective endocarditis-related mortality with a management-based approach. Arch Intern Med. 2009 Jul 27;169(14):1290-8.Texto completo Resumo
93. Gupta R, Kaushal V, Goyal A, et al. Changing microbiological profile and antimicrobial susceptibility of the isolates obtained from patients with infective endocarditis - the time to relook into the therapeutic guidelines. Indian Heart J. 2021 Nov-Dec;73(6):704-10.Texto completo Resumo
94. Murray HW, Wigley FM, Mann JJ, et al. Combination antibiotic therapy in staphylococcal endocarditis: the use of methicillin sodium-gentamicin therapy. Arch Intern Med. 1976 Apr;136(4):480-3. Resumo
95. Korzeniowski O, Sande MA. Combination antimicrobial therapy for Staphylococcus aureus endocarditis in patients addicted to parenteral drugs and in nonaddicts: a prospective study. Ann Intern Med. 1982 Oct;97(4):496-503. Resumo
96. Cosgrove SE, Vigliani GA, Fowler VG Jr., et al. Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxic. Clin Infect Dis. 2009 Mar 15;48(6):713-21.Texto completo Resumo
97. Chirouze C, Cabell CH, Fowler VG Jr, et al. Prognostic factors in 61 cases of Staphylococcus aureus prosthetic valve infective endocarditis from the International Collaboration on Endocarditis merged database. Clin Infect Dis. 2004 May 1;38(9):1323-7.Texto completo Resumo
98. John MD, Hibberd PL, Karchmer AW, et al. Staphylococcus aureus prosthetic valve endocarditis: optimal management and risk factors for death. Clin Infect Dis. 1998 Jun;26(6):1302-9. Resumo
99. Rusu A, Munteanu AC, Arbănași EM, et al. Overview of side-effects of antibacterial fluoroquinolones: new drugs versus old drugs, a step forward in the safety profile? Pharmaceutics. 2023 Mar 1;15(3):804.Texto completo Resumo
100. Meena DS, Kumar D, Agarwal M, et al. Clinical features, diagnosis and treatment outcome of fungal endocarditis: a systematic review of reported cases. Mycoses. 2022 Mar;65(3):294-302. Resumo
101. Ellis ME, Al-Abdely H, Sandridge A, et al. Fungal endocarditis: evidence in the world literature, 1965-1995. Clin Infect Dis. 2001 Jan;32(1):50-62.Texto completo Resumo
102. Wen W, Li H, Wang C, et al. Efficacy and safety of outpatient parenteral antibiotic therapy in patients with infective endocarditis: a meta-analysis. Rev Esp Quimioter. 2022 Aug;35(4):370-7.Texto completo Resumo
103. Phillips MC, Wald-Dickler N, Davar K, et al. Choosing patients over placebos: oral transitional therapy vs. IV-only therapy for bacteraemia and infective endocarditis. Clin Microbiol Infect. 2023 Sep;29(9):1126-32.Texto completo Resumo
104. Krishna MT, Vedanthan PK, Vedanthan R, et al. Is spurious penicillin allergy a major public health concern only in high-income countries? BMJ Glob Health. 2021 May;6(5):e005437.Texto completo
105. Tleyjeh IM, Kashour T, Zimmerman V, et al. The role of valve surgery in infective endocarditis management: a systematic review of observational studies that included propensity score analysis. Am Heart J. 2008 Nov;156(5):901-9. Resumo
106. Pettersson GB, Coselli JS, Hussain ST, et al. 2016 The American Association for Thoracic Surgery (AATS) consensus guidelines: surgical treatment of infective endocarditis - executive summary. J Thorac Cardiovasc Surg. 2017 Jun;153(6):1241-58. Resumo
107. Wang A, Fosbøl EL. Current recommendations and uncertainties for surgical treatment of infective endocarditis: a comparison of American and European cardiovascular guidelines. Eur Heart J. 2022 May 1;43(17):1617-25.Texto completo Resumo
108. Anantha Narayanan M, Mahfood Haddad T, Kalil AC, et al. Early versus late surgical intervention or medical management for infective endocarditis: a systematic review and meta-analysis. Heart. 2016 Jun 15;102(12):950-7. Resumo
109. Hoen B, Duval X. Clinical practice. Infective endocarditis. N Engl J Med. 2013 Apr 11;368(15):1425-33. Resumo
110. Tornos P, Almirante B, Mirabet S, et al. Infective endocarditis due to Staphylococcus aureus: deleterious effect of anticoagulant therapy. Arch Intern Med. 1999 Mar 8;159(5):473-5.Texto completo Resumo
111. Chan KL, Dumesnil JG, Cujec B, et al. A randomized trial of aspirin on the risk of embolic events in patients with infective endocarditis. J Am Coll Cardiol. 2003 Sep 3;42(5):775-80.Texto completo Resumo
112. Kusminsky RE. Complications of central venous catheterization. J Am Coll Surg. 2007 Apr;204(4):681-96.Texto completo Resumo
113. McGee DC, Gould MK. Preventing complications of central venous catheterization. N Engl J Med. 2003 Mar 20;348(12):1123-33.Texto completo Resumo
114. Smith RN, Nolan JP. Central venous catheters. BMJ. 2013 Nov 11;347:f6570.Texto completo Resumo
115. Reich DL. Monitoring in anesthesia and perioperative care. Cambridge: Cambridge University Press; 2011.
116. Abbott Northwestern Hospital Internal Medicine Residency. Internal jugular central venous line. 2015 [internet publication].Texto completo
117. Bishop L, Dougherty L, Bodenham A, et al. Guidelines on the insertion and management of central venous access devices in adults. Int J Lab Hematol. 2007 Aug;29(4):261-78.Texto completo Resumo
118. Practice guidelines for central venous access 2020: an updated report by the American Society of Anesthesiologists Task Force on Central Venous Access. Anesthesiology. 2020 Jan;132(1):8-43.Texto completo Resumo
119. Fletcher SJ, Bodenham AR. Safe placement of central venous catheters: where should the tip of the catheter lie? Br J Anaesth. 2000 Aug;85(2):188-91.Texto completo
120. Gibson F, Bodenham A. Misplaced central venous catheters: applied anatomy and practical management. Br J Anaesth. 2013 Mar;110(3):333-46.Texto completo
121. Schuster M, Nave H, Piepenbrock S, et al. The carina as a landmark in central venous catheter placement. Br J Anaesth. 2000 Aug;85(2):192-4.Texto completo
122. Webster J, Osborne S, Rickard CM, et al. Clinically-indicated replacement versus routine replacement of peripheral venous catheters. Cochrane Database Syst Rev. 2019 Jan 23;1(1):CD007798.Texto completo Resumo
123. Patterson TF, Thompson GR 3rd, Denning DW, et al. Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016 Aug 15;63(4):e1-60.Texto completo Resumo
124. Pappas PG, Kauffman CA, Andes DR, et al. Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016 Feb 15;62(4):e1-50.Texto completo Resumo
125. Douglas AP, Smibert OC, Bajel A, et al. Consensus guidelines for the diagnosis and management of invasive aspergillosis, 2021. Intern Med J. 2021 Nov;51 Suppl 7:143-76.Texto completo Resumo
126. De Vito A, Fiore V, Colpani A, et al. The current and future off-label uses of dalbavancin: a narrative review. Eur Rev Med Pharmacol Sci. 2023 Feb;27(3):1222-38.Texto completo Resumo
127. Gatti M, Andreoni M, Pea F, et al. Real-world use of dalbavancin in the era of empowerment of outpatient antimicrobial treatment: a careful appraisal beyond approved indications focusing on unmet clinical needs. Drug Des Devel Ther. 2021 Aug 3:15:3349-78.Texto completo Resumo
128. Mhanna M, Beran A, Al-Abdouh A, et al. AngioVac for vegetation debulking in right-sided infective endocarditis: a systematic review and meta-analysis. Curr Probl Cardiol. 2022 Nov;47(11):101353. Resumo
129. Habib G, Erba PA, Iung B, et al. Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study. Eur Heart J. 2019 Oct 14;40(39):3222-32.Texto completo Resumo
130. Sexton DJ, Spelman D. Current best practices and guidelines: assessment and management of complications of infective endocarditis. Cardiol Clin. 2003 May;21(2):273-82. Resumo
131. Mills J, Utley J, Abbott J. Heart failure in infective endocarditis: predisposing factors, course, and treatment. Chest. 1974 Aug;66(2):151-7. Resumo
132. Hoen B, Alla F, Selton-Suty C, et al; Association pour l'Etude et la Prévention de l'Endocardite Infectieuse (AEPEI) Study Group. Changing profile of infective endocarditis: results of a 1-year survey in France. JAMA. 2002 Jul 3;288(1):75-81.Texto completo Resumo
133. Sanfilippo AJ, Picard MH, Newell JB, et al. Echocardiographic assessment of patients with infective endocarditis: prediction of risk for complications. J Am Coll Cardiol. 1991 Nov 1;18(5):1191-9.Texto completo Resumo
134. Mohananey D, Mohadjer A, Pettersson G, et al. Association of vegetation size with embolic risk in patients with infective endocarditis: a systematic review and meta-analysis. JAMA Intern Med. 2018 Apr 1;178(4):502-10.Texto completo Resumo
135. Yang A, Tan C, Daneman N, et al. Clinical and echocardiographic predictors of embolism in infective endocarditis: systematic review and meta-analysis. Clin Microbiol Infect. 2019 Feb;25(2):178-187.Texto completo Resumo
136. Alsip SG, Blackstone EH, Kirklin JW, et al. Indications for cardiac surgery in patients with active infective endocarditis. Am J Med. 1985 Jun 28;78(6B):138-48. Resumo
137. Kupferwasser LI, Yeaman MR, Nast CC, et al. Salicylic acid attenuates virulence in endovascular infections by targeting global regulatory pathways in Staphylococcus aureus. J Clin Invest. 2003 Jul;112(2):222-33.Texto completo Resumo
138. Chan KL, Tam J, Dumesnil JG, et al. Effect of long-term aspirin use on embolic events in infective endocarditis. Clin Infect Dis. 2008 Jan 1;46(1):37-41.Texto completo Resumo
139. Anavekar NS, Tleyjeh IM, Mirzoyev Z, et al. Impact of prior antiplatelet therapy on risk of embolism in infective endocarditis. Clin Infect Dis. 2007 May 1;44(9):1180-6.Texto completo Resumo
140. Steckelberg JM, Murphy JG, Ballard D, et al. Emboli in infective endocarditis: the prognostic value of echocardiography. Ann Intern Med. 1991 Apr 15;114(8):635-40. Resumo
141. Heiro M, Nikoskelainen J, Engblom E, et al. Neurologic manifestations of infective endocarditis: a 17-year experience in a teaching hospital in Finland. Arch Intern Med. 2000 Oct 9;160(18):2781-7. Resumo
142. Huston J 3rd, Nichols DA, Luetmer PH, et al. Blinded prospective sensitivity of MR angiography to known intracranial aneurysms: importance of aneurysm size. AJNR Am J Neuroradiol. 1994 Oct;15(9):1607-14. Resumo
143. Darjee R, Gibb AP. Serological investigation into the association between Streptococcus bovis and colonic cancer. J Clin Pathol. 1993 Dec;46(12):1116-9.Texto completo Resumo
144. Niwa K, Nakazawa M, Tateno S, et al. Infective endocarditis in congenital heart disease: Japanese national collaboration study. Heart. 2005 Jun;91(6):795-800.Texto completo Resumo
145. Moller JH, Anderson RC. 1,000 consecutive children with a cardiac malformation with 26- to 37-year follow-up. Am J Cardiol. 1992 Sep 1;70(6):661-7. Resumo
O uso deste conteúdo está sujeito ao nosso aviso legal